Topic

Texas

A collection of 390 issues

How to Get Procysbi (Cysteamine Bitartrate DR) Covered by Cigna in Texas: Prior Authorization, Appeals, and Step Therapy Guide

Answer Box: Getting Procysbi Covered by Cigna in Texas Cigna requires prior authorization for Procysbi (cysteamine bitartrate delayed-release) and mandates step therapy with immediate-release cysteamine (Cystagon) first. To get coverage in Texas: (1) Document failed/intolerant trial of Cystagon, (2) Submit PA with genetic testing and WBC cystine levels, (3)
4 min read

How to Get Ibrance (Palbociclib) Covered by UnitedHealthcare in Texas: Prior Authorization Guide and Appeals Process

Answer Box: Getting Ibrance Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Ibrance (palbociclib) in Texas, with specific criteria for HR+/HER2- advanced breast cancer. The fastest path to approval: (1) Submit complete PA documentation showing HR+/HER2- diagnosis, intended combination with aromatase inhibitor or fulvestrant, and prior
6 min read

Renewing Cosentyx (Secukinumab) Approval with UnitedHealthcare in Texas: Documentation Guide & Timeline

Answer Box: Renewing Cosentyx with UnitedHealthcare in Texas UnitedHealthcare requires documented clinical response and specific therapy conditions for Cosentyx renewal in Texas. Submit renewal documentation 30-60 days before your current authorization expires. Key requirements: proof of positive clinical response (PASI/DLQI scores), confirmation you're not combining with other
5 min read

How to Get Strimvelis Gene Therapy Covered by Aetna CVS Health in Texas: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Getting Strimvelis Covered by Aetna CVS Health in Texas Strimvelis requires prior authorization from Aetna CVS Health with genetic confirmation of ADA-SCID, enzyme deficiency evidence, and proof no HLA-matched donor is available. Submit through Availity or fax (1-866-249-6155) with comprehensive clinical documentation. Standard review takes up to 45
6 min read

How Long Does It Take to Get Nucala (Mepolizumab) Approved by Blue Cross Blue Shield in Texas? Complete Timeline & Appeals Guide

Answer Box: Getting Nucala Approved in Texas Blue Cross Blue Shield of Texas typically takes 3-15 business days to approve Nucala (mepolizumab) with complete documentation. Fastest path: Submit prior authorization through your specialist with eosinophil count ≥150 cells/μL, documented exacerbations, and evidence of failed step therapy alternatives. Start today:
5 min read